Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
TGF-beta1: immunosuppressant and viability factor for T lymphocytes.
Recruiting the occupational and environmental medicine physicians of the future: results of a survey of current residents.
Light Coagulation
PPARgamma as a therapeutic target in central nervous system diseases.
See All 15 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PPARgamma as a therapeutic target in central nervous system diseases.
Sundararajan S, Jiang Q, Heneka M, Landreth G. PPARgamma as a therapeutic target in central nervous system diseases. Neurochem Int. 2006 Jul; 49(2):136-44.
View in:
PubMed
subject areas
Animals
Anti-Inflammatory Agents
Brain
Brain Diseases
Disease Models, Animal
Encephalitis
Gene Expression Regulation
Humans
Inflammation Mediators
Neuroprotective Agents
PPAR gamma
Transcriptional Activation
authors with profiles
Michael Thomas Heneka MD